Background The concordance of haemovigilance criteria developed for surveillance of transfusion-associated circulatory overload (TACO) with its clinical diagnosis has not been assessed. In a pilot study to evaluate an electronic screening algorithm, we sought to examine TACO incidence and application of haemovigilance criteria in patients with post-transfusion pulmonary oedema.
Introduction
Severe, non-infectious adverse transfusion reactions are receiving greater attention with an increased focus on their prevention [1] . Systematic data gathering efforts have improved our understanding of the incidence of pulmonary transfusion reactions such as transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO). In this regard, both the International Society of Blood Transfusion (ISBT) and the US National Healthcare Safety Network (NHSN) have provided criteria for surveillance of pulmonary reactions (see Appendix S1) and each has promulgated a system of data gathering [2] [3] [4] .
While national haemovigilance systems are valuable and contribute to our understanding of transfusion reactions, a significant limitation is that reactions are captured by a passive reporting system, thereby underestimating true incidence [5] [6] [7] . Active surveillance for severe transfusion reactions may offer a more accurate assessment of the incidence and characterization of severe transfusion-related acute adverse events and provide insight on how to refine haemovigilance criteria to be more sensitive and specific [8, 9] .
With the rapid expansion of electronic medical records, algorithms to screen for and identify cases of post-transfusion pulmonary oedema are becoming more common [8] [9] [10] [11] . However, distinguishing the aetiology of pulmonary transfusion reactions often poses a diagnostic challenge [12, 13] . The utility of applying haemovigilance system definitions developed for surveillance of pulmonary transfusion reactions to all transfused patients has not been examined, although there are ongoing efforts to re-evaluate and improve the specificity of these definitions [4, 14, 15] .
Our first objective in this multicentre study was to implement and validate an automated screening algorithm for post-transfusion pulmonary oedema among all transfused patients in order to estimate TACO incidence. Our additional objectives were to compare clinical and surveillance definitions for TACO and to identify additional relevant clinical variables captured in this process which might improve the classification of pulmonary reactions as TACO.
Methods

Study design and subjects
As part of the NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III), prospective surveillance for cases of pulmonary transfusion reactions was conducted between June and September 2014 at four tertiary care hospitals. Cases of pulmonary transfusion reactions were identified by active surveillance of all adult hospitalized patients transfused with red blood cells, platelets, or plasma. The protocol was approved, including a waiver of consent, by institutional review boards of all participating sites [Aurora St. Luke's Medical Center (ASLMC), University of California San Francisco (UCSF), University of Pittsburgh Medical Center (UPMC) and Yale New Haven Hospital (YNHH)].
The study design involved four hierarchical layers of screening and diagnosis: (i) an electronic algorithm flagged cases where a chest radiograph was ordered within 12 h of blood product release; (ii) research nurses reviewed all alerted cases for new or worsening hypoxia and suspected pulmonary oedema based on radiography reports within 12 h of transfusion; (iii) a pulmonary physician (NHR) triaged the co-ordinators' cases and ruled out exclusionary diagnoses; and (iv) cases were then reviewed by a three-member expert panel consisting of critical care specialists with expertise in transfusion medicine (DJK, MRL, MAM). Screening, record review, data entry and case adjudication occurred via a centralized Study Management System (SMS) managed by RTI, the REDS-III Data Coordinating Center.
Subjects were excluded from further screening if they did not receive a transfusion; that is, blood was issued but not transfused. Further exclusion criteria included (i) no chest radiograph (ordered but not performed); (ii) no evidence for pulmonary oedema on chest radiograph; (iii) improvement or no change in pre-existing pulmonary oedema; (iv) no increase in supplementary oxygen; or (v) presence of conditions that could be mistaken for pulmonary oedema on chest radiograph (e.g. recent lung transplantation, pulmonary fibrosis). Additionally subjects receiving extracorporeal membrane oxygenation (ECMO), in whom measures of oxygenation would be confounded, and routine postcardiac surgery patients without significant pulmonary oedema or increased oxygen requirements, were excluded. The disposition/classification of each screened case including inclusion and exclusion criteria was recorded in the SMS.
Research nurses completed extensive standardized study data forms and prepared standardized narrative reports from electronic medical record data. The case synopses included the clinical context and timeline of events, number and volumes of transfused blood components as well as fluids, chest radiograph images and reports, respiratory and haemodynamic monitoring data, echocardiography and laboratory results. These summaries were provided to the expert panel to determine the aetiology of possible pulmonary transfusion reactions. Each case was initially reviewed by two experts who independently classified it as TACO, TRALI including Possible TRALI, TACO/TRALI or 'Other' when an alternative diagnosis was identified. If the two experts independently agreed on a diagnosis, the classification was final. If the two experts did not agree, the third expert reviewed the case. If two of the three panel members agreed on a final diagnosis, the case was considered adjudicated. On periodic conference calls, all three members of the expert panel reviewed cases without two experts in agreement to discuss the case in more depth and assign a consensus determination.
A clinical diagnosis of TACO was derived from criteria used in the NHSN surveillance definition, namely with pulmonary oedema developing within 6 h of transfusion characterized by clinical, echocardiographic or laboratory evidence of left atrial hypertension along with clinical judgment using other case information (See Appendix S2 for listing of available data) [2] . TRALI was defined as new acute lung injury (ALI) that developed within 6 h of transfusion, and there was no temporal relationship to an alternative risk factor for ALI (See Appendix S2). Cases designated as Possible TRALI in this study were patients where the expert panel believed that the underlying ALI risk factor was likely to have played a significant role in the development of pulmonary oedema. Lastly, cases were designated as TACO/TRALI when the expert panel could not distinguish between the two diagnoses. Case classification by the expert panel was compared with strict application of NHSN and proposed revised ISBT haemovigilance criteria (See Appendix S1).
Statistical analysis
For incidence calculations, the total number of transfused components and number of unique transfused patients during the study period were captured from the hospital transfusion service. Individual transfusion episodes were defined as blood components released within 6 h of one another. Distributions and proportions of demographic and clinical data were tabulated for groups of pulmonary transfusion reactions. Data were expressed as mean values -standard deviation (SD), medians or proportions and were compared using chi-square tests, t-test and Wilcoxon rank sum test, as appropriate. A multivariate logistic regression model was developed to identify how risk factors (demographics and clinical variables in Appendix S3) were associated with TACO and non-TACO cases. The initial model was refined using backward elimination at the P = 0Á05 level to retain significant variables. After the final covariates were selected, interactions were investigated. Receiver operating characteristic curves (ROC) and area under the curve (AUC) were generated to compare the models' predictive accuracy and select the optimum model. The final model was also subjected to the Hosmer-Lemeshow test for goodness of fit. A twotailed P value of less than 0Á05 was considered statistically significant. Statistical analysis was performed with SAS/STAT software, Version 9.4, Cary, NC, USA
Results
Among 14 300 transfusion episodes during the study period, electronic surveillance generated 3412 alerts from a total of 4982 patients transfused 30 837 blood components ( Fig. 1 , Table S1 . The automated algorithm at each hospital was audited against transfusion reactions reported to the blood bank as well as through a review of 50 randomly selected transfusion episodes. 2Á8% (97/ 3412) of alerts were reviewed by the expert panel who diagnosed 50 cases of TACO and 47 cases of other diagnoses ('non-TACO'). These non-TACO diagnoses included 29 cases of Possible TRALI or TRALI, 2 cases of TACO/ TRALI and 16 cases of alternative causes of bilateral pulmonary opacities (Table 1) . Aetiologies of these 16 'Other' cases included: atelectasis (4), pneumonia (4), aspiration (2), mild postcardiac surgery oedema (2), neurogenic pulmonary oedema (1), cardiogenic shock (1), negative pressure pulmonary oedema (1) and diffuse alveolar haemorrhage (1). 1Á5% (50/3412) of alerts did not meet the exclusion criteria ( Fig. 1 ) and resulted in a diagnosis of TACO. Using the denominator of all unique patients transfused at each hospital over the study period, we estimated an incidence of 1 TACO cases per 100 patients transfused (50/4982). Incidence rates were similar across the four hospitals (Range: 0Á9-1Á1 case per 100 patients transfused). Across all four centres, there were 3Á5 TACO cases per 1000 transfusion episodes (50/14 300).
Clinical data corresponding to parameters included in the NHSN and proposed revised ISBT haemovigilance criteria for TACO were extracted from extended form data (Table S2 ) and case classification using these criteria were compared to expert panel diagnoses. Of the 97 patients with pulmonary oedema referred for expert panel review, NHSN and proposed revised ISBT consensus criteria resulted in 23 (46%) and 22 (44%) more cases of TACO, respectively; and haemovigilance system classifications were concordant with expert panel review in 57% and 54% of cases, respectively (See Table 2 ). Using either of the haemovigilance criteria, we estimated an incidence of 1Á4 TACO cases per 100 patients transfused. Hospital mortality was higher for cases classified as TACO using NHSN (28%) or ISBT (29%) criteria relative to that of expert panel diagnosis (14%; P = 0Á05). Tables 3 and 4 provide a description of the clinical characteristics and comorbid conditions in cases of expert panel adjudicated TACO compared to those with other causes of post-transfusion pulmonary oedema. Patients with TACO were older and had a greater prevalence of cardiac disease (congestive heart failure and coronary artery disease) as well as a history of COPD. There were TACO, transfusion-associated circulatory overload; TRALI, transfusionrelated acute lung injury. Number of blood components given in the 6 or 24 h prior to development of pulmonary oedema.
no differences in the number of units transfused in 6 and 24 h prior to developing pulmonary oedema, nor was there a difference in overall fluid balance. Total volumes of transfused blood components were non-statistically higher in cases of TACO, and TACO was more common in patients receiving plasma alone or with RBC's (P = 0Á04) though not in those receiving both platelets and plasma (P = 0Á39). The frequency of obtaining diagnostic tests that are included as part of haemovigilance criteria for TACO was as follows: echocardiogram data were available in 67% of cases -either prior to or following transfusion; central venous pressure and BNP levels were measured in 39% and 5% of cases, respectively. Table 5 provides oxygenation and haemodynamic characteristics of patients with TACO compared with other diagnoses. There were no significant differences in the proportion of patients receiving mechanical ventilation at the time of pulmonary oedema. The severity of pulmonary oedema based on chest radiograph reports (mild/moderate/severe) was also similar in cases of TACO vs. other diagnoses. In TACO cases, signs and symptoms of pulmonary oedema (dyspnoea, tachypnoea or increased oxygen requirements) were more likely to resolve within the first 24 h following transfusion (P = 0Á01). Oxygenation, as measured either by PaO2/ FiO2 or SpO2/FiO2 ratios within 24 h of pulmonary oedema as well as the change in oxygenation from the time of oedema, was higher in cases of TACO vs. other diagnoses (P 0Á05 & 0Á01, respectively). In our multivariable regression analysis, only a history of congestive heart failure, a history of chronic obstructive pulmonary disease and the PaO2/FiO2 ratio within 24 h of pulmonary oedema were significant in the final model of TACO vs. non-TACO cases (AUC 0Á74; Hosmer-Lemeshow goodness-of-fit test P = 0Á34)
Discussion
For this study, we successfully implemented a system of active surveillance using electronic medical record screening and case review for pulmonary transfusion reactions. TACO incidence was similar across four academic hospitals and was similar to prior studies utilizing other active surveillance systems. Application of haemovigilance criteria to all cases of transfusion-related pulmonary oedema showed a substantial rate of TACO, transfusion-associated circulatory overload, COPD, chronic obstructive pulmonary disease. discordance with the expert panel's clinical diagnoses of TACO. Notably, TACO cases identified using haemovigilance criteria had a higher mortality rate. Diagnostic tests used as part of haemovigilance criteria, such as BNP levels, were uncommonly utilized clinically. Many clinical risk factors -including transfusion volumes and fluid balance -did not distinguish TACO from other causes of transfusion-associated pulmonary oedema. However, improvement in readily available measures of oxygenation occurred more frequently in TACO and merits further evaluation in its diagnosis.
We developed our automated screening algorithm with the intent of having excellent sensitivity but not necessarily high specificity in four different hospital settings. Our limited auditing indicated that this algorithm did not miss any TACO cases; however, we recognize that the high number of cases generating alerts for further review (e.g. 24% of all transfusion episodes) makes its use impractical outside of a research setting. Subsequent modifications of the automated algorithm to exclude alerts without transfusion or chest radiographs and to include measures of oxygenation improved the specificity modestly from 2Á8% to 10% in a pilot at one site. However, further modifications would be needed to decrease the false-positive alert rate if this approach is to be considered for surveillance of pulmonary transfusion reactions. Our study found a perpatient incidence rate of TACO similar to that of other prospective cohorts with some degree of active surveillance but lower compared to studies focused on a specific patient population or blood component type [6, 9, 16] . We also utilized a new metric -a per transfusion episode incidence -which we believe is meaningful as it reflects each opportunity for a patient to develop TACO. We found that TACO incidence per transfusion episode was one-third that of per-patient incidence.
A notable finding was that relevant diagnostic data were often not available clinically at the time of a pulmonary transfusion reaction. Echocardiography which can provide useful non-invasive information regarding the pathogenesis of post-transfusion pulmonary oedema was utilized in approximately two-thirds of the study population. Measurement of central venous pressure was only sporadically utilized even in critically ill patients with central venous catheters. Most striking was the infrequent ordering of brain natriuretic peptide (BNP), occurring in only 5% of cases. This finding parallels a review of TACO which found that BNP levels were only measured in 3% (3/98) and 11% (11/98) of cases prior to and following the development of pulmonary oedema, respectively [17] . Studies have found higher BNP and NT-proBNP levels in TACO patients in comparison with those of patients with TRALI and Possible TRALI, and more recently, elevations in inflammatory cytokines have been recognized in TRALI but not in TACO [8, [18] [19] [20] [21] . Whether increased use of BNP alone or in combination with other inflammatory markers would be beneficial in the differential diagnosis of transfusion-associated pulmonary oedema remains unclear and merits further study [20, 22] .
The vast majority of the 97 subjects evaluated by the expert panel had acute respiratory distress, radiographic evidence of pulmonary oedema, and a positive fluid balance -sufficient for diagnosis of TACO using NHSN criteria but not by clinical criteria used by our panel [2] . Our study, as others have reported, found that fluid balance was not useful in differentiating TACO from other forms of transfusion-related pulmonary oedema [10, 18, 20, 23] . Incorporating the clinical context, chest radiograph images, invasive haemodynamic monitoring data and echocardiography data likely provided the expert panel with additional details in determining the most likely aetiology of the pulmonary oedema. When applied strictly, two haemovigilance definitions for TACO were frequently discordant with expert panel review and resulted in inclusion of additional cases of TACO. The impact of these additional cases on our reported incidence of TACO was relatively small, with incidence using either clinical diagnosis or haemovigilance criteria in line with what has been reported in studies of active surveillance. However, mortality rates using haemovigilance criteria were higher than that of expert panel diagnoses and what has been reported in prior studies [24, 25] . Strict application of haemovigilance criteria for TACO resulted in the inclusion of cases which were clinically classified by the expert panel as Other or Possible TRALI; the latter which is known to have a higher mortality rate than TACO [11] . While differences between the mortality rates by haemovigilance classification and those reported in the literature in clinical case series may be due to specific comorbidities or concurrent risk factors, future studies should specify the methodology used in case classification when reporting clinical outcomes.
It is well known that distinguishing pulmonary transfusion reactions requires clinical data that are labour intensive to extract and require experience to interpret. In an effort to improve the sensitivity and specificity of haemovigilance criteria, the ISBT Working Party on Haemovigilance has endeavoured to revise the ISBT definition of TACO [4, 14] . However, given that the currently utilized diagnostic criteria for TACO contain data variables that are only obtained sporadically or lack specificity, others need to be identified and examined for their potential utility. Variables considered in the revised diagnosis of TACO, including the presence of cardiomegaly on chest radiographs or the impact of diuretics (at least net negative 1 litre within 24 h) were infrequently available in our study and not different in TACO from other cases of pulmonary oedema [4, 14] . The use of diuretics as a treatment for TACO (60%) was higher compared to two prior studies (29% and 27%), but in our cohort, their use was also common for other causes of pulmonary oedema (45%) [17, 23] .
We also found that the severity of pulmonary oedema as graded on chest radiograph reports and by measures of oxygenation was similar in cases of TACO and other forms of pulmonary oedema. However, within 24 h of transfusion, measures of oxygenation had improved significantly in cases of TACO, and these improvements were independently associated with a diagnosis of TACO in our multivariable regression analysis. These improvements in oxygenation may correlate with resolution of pulmonary oedema radiographically. Radiographic changes in pulmonary oedema were included as part of the adjudication process and time to improvement in symptomatic, radiographic or oxygenation parameters after transfusion may be useful in the post hoc diagnosis of TACO.
This study has both strengths and limitations. Strengths include the use of active surveillance in a multicentre study population composed of both medical and surgical patients, the use of an electronic screening algorithm, the collection of detailed clinical data and expert panel review for outcome adjudication. However, despite the high sensitivity of case identification, the accuracy of estimated incidence rates of pulmonary transfusion reactions may be limited by the short study period. An ongoing case-control study of TACO at the study hospitals will address this limitation by including a larger sample size and imputability criteria and will additionally examine the role of BNP in classifying cases where adequate clinical data are not available [26] .
Given the advent of electronic medical record surveillance of pulmonary transfusion reactions, we can expect increased identification of complex cases of posttransfusion pulmonary oedema. While providing some guidance in their identification, surveillance definitions of pulmonary transfusion reactions would benefit from enhanced specificity to help differentiate complicated clinical cases. Identifying additional clinical or biomarker predictors which further incorporate the pathophysiology of these specific clinical entities will hopefully improve classification of pulmonary transfusion reactions.
